Current Studies
Click on a study for more information
We are currently enrolling in studies for Alzheimer’s Disease.
Please contact Estela at 619-432-0867.
Simufilam 50 mg Or 100 mg For Mild-To-Modeate Alzheimer’s Disease (REFOCUS_ALZ).https://clinicaltrials.gov/ct2/show/NCT05026177
A study of LY3372689 To Assess The Safety, Tolerability, And Efficacy In Participants With Alzheimer’s Disease.https://clinicaltrials.gov/ct2/show/NCT05063539
For more information, you can visit the patient website by clicking here
We are currently enrolling in studies for Myasthenia Gravis.
Please contact Lupe at 619-432-0954.
Descartes-08 CAR-T Cells In Generalized Myasthenia Gravis (MG).https://clinicaltrials.gov/ct2/show/NCT04146051
Evaluating The Long Term Safety And Tolerability Of Efgartigimond PH20 SC Administered Subcutaneously In Patients With Generalized Myasthenia Gravis (ADAPTSC+).https://clinicaltrials.gov/ct2/show/NCT04818671
We are currently enrolling in studies for Multiple Sclerosis.
Please contact Lupe at 619-432-0954.
A Study To Evaluate The Efficacy And Safety of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (Fenhance) .https://clinicaltrials.gov/ct2/show/NCT04586010
For more information, you can visit the patient website by clicking here.
We are currently enrolling in studies for Migraine.
Please contact April at 619-432-0859.
Assessment of Safety of Nerivio for the Migraine Prevention .https://clinicaltrials.gov/ct2/show/NCT04828707
We are currently enrolling in studies for Multiple System Atrophy, Pure Autonomic Failure, and Lewy Body Dementia.
Please contact April at 619-432-0859
Synuclein-One Study .https://clinicaltrials.gov/ct2/show/NCT04700722
Current Areas of Research
Alzheimer's Disease/Dementia
Headache/Migraine
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)